[登录] [免费注册]
试剂仪器网
发布求购
位置：首页 > 产品库 > 产品列表
产品搜索：  
[5015]...[3398]... [1423] [1422] [1421] [1420] [1419] [1418] [1417] [1416] [1415] [1414] [1413] [1412] [1411] ...[775]... [1]
共300871条，60条/页，显示第1422页
序号CAS产品名称规格包装 参考价格
1111025-46-8 Pioglitazone 询价
280325-22-0 Gypenoside XIII 询价
3110261-98-8 Gypenoside LXXV 1mg询价
4157752-01-7 Gypenoside A 询价
5899430-03-6 Gymnoside III 1mg询价
622978-25-2 GW9662 询价
7939028-75-8 pNP-ADPr 询价
82412923-11-4 TFMU-ADPr 询价
92032096-45-8 PDD00031705 询价
10314248-24-3 COH34 analog 1 询价
116505-99-3 JA2131 询价
12 TFMU-ADPr ammonium 询价
131952247-05-0 PDD00017238 询价
141945950-20-8 PDD00017272 询价
15906439-72-3 COH34 询价
161945950-21-9 PDD 00017273 询价
17173529-46-9 HMN-214 询价
18321688-88-4 Poloxin 询价
191052532-15-6 SBE13 Hydrochloride 询价
20244240-24-2 LFM-A13 询价
211228960-69-7 MLN0905 询价
221082739-92-1 TC-S 7005 询价
231137868-52-0 TAK-960 询价
241062243-51-9 Ro3280 询价
25592542-60-4 Rigosertib sodium 询价
261312471-39-8 ON1231320 询价
27592542-59-1 Rigosertib 询价
28660868-91-7 GW843682X 询价
291798871-31-4 Centrinone-B 询价
30929095-18-1 GSK461364 询价
311034616-18-6 Onvansertib 询价
321798871-30-3 Centrinone 询价
33755038-65-4 Volasertib 询价
341428630-85-6 VU0424465 询价
351240390-27-5 GSK143 询价
361337531-83-5 PERK-IN-2 询价
372616821-92-0 (S)-PERK-IN-5 询价
38 YF135 询价
391125632-93-0 Takeda-6d 询价
40459841-96-4 ONO-8130 询价
412341796-81-2 GSK143 dihydrochloride 询价
421337531-89-1 PERK-IN-4 询价
431523437-16-2 ML291 询价
442616821-91-9 PERK-IN-5 询价
45864388-65-8 MK-28 询价
4677111-29-6 NSC 295642 询价
472653994-08-0 Opnurasib 询价
482653994-10-4 (S)-JDQ-443 询价
491883548-84-2 AMG PERK 44 询价
50324759-76-4 CCT020312 询价
511337532-29-2 GSK2656157 询价
521337531-36-8 GSK2606414 询价
531401089-31-3 PACMA 31 询价
541069858-99-6 ML359 询价
552285446-62-8 E64FC26 询价
5632502-62-8 3-Methyltoxoflavin 询价
57346640-08-2 CCF642 询价
582630950-38-6 VCP/p97 inhibitor-1 询价
591883351-01-6 UPCDC-30245 5mg询价
601863952-15-1 CB-5339 询价
共300871条，60条/页，显示第1422页
[5015]...[3044]... [1433] [1432] [1431] [1430] [1429] [1428] [1427] [1426] [1425] [1424] [1423] [1422] [1421] ...[639]... [1]